Related Experiment Video
Updated: Mar 7, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.5K
[Diabetology as an interdisciplinary challenge].
1I. Medizinische Klinik, Universitätsklinikum Aachen, Pauwelsstr. 30, 50724, Aachen, Deutschland. dirmueller@ukaachen.de.
Der Internist
|February 25, 2017
Summary
Type 2 diabetes management requires integrated care addressing prevention, patient-centered therapy, and social factors. New drugs like empagliflozin show promise in reducing cardiovascular events and heart failure hospitalizations in high-risk patients.
Area of Science:
- Cardiology
- Endocrinology
- Public Health
Background:
- Type 2 diabetes mellitus is a growing global health concern.
- Cardiovascular complications and multimorbidity significantly impact patient prognosis.
- Patients with diabetes hospitalized for heart failure face a high mortality rate.
Purpose of the Study:
- To outline an interdisciplinary approach to diabetes care.
- To emphasize the need for screening, prevention, and patient-centered drug therapy.
- To highlight strategies for managing complex comorbidities in diabetes patients.
Main Methods:
- Review of clinical prognosis factors in type 2 diabetes.
- Analysis of therapeutic options, including GLP-1 receptor agonists and SGLT-2 inhibitors.
- Examination of interdisciplinary care models for diabetes comorbidities.
Main Results:
- Empagliflozin demonstrated significant reduction in cardiovascular event rates and heart failure hospitalizations.
- Liraglutide also showed benefits in reducing cardiovascular event rates.
- The European Society of Cardiology now includes SGLT-2 inhibitors in heart failure guidelines.
Conclusions:
- Integrated, interdisciplinary care is crucial for managing type 2 diabetes and its complications.
- Pharmacological advancements, such as SGLT-2 inhibitors, offer improved cardiovascular outcomes.
- A holistic approach encompassing prevention, tailored therapy, and social support is essential.
Keywords:
AntidiabeticsCardiovascular riskDiabetes mellitus, type 2, therapyHeart failurePrevention and control, diabetesMore Related Videos
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
1.2K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
01:20Pathophysiology of Diabetes
4.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.0K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.6K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.6K
01:22Diabetes Mellitus: Overview and Type I Subtype
5.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.7K
01:22Diabetes Mellitus: Type 2 and Gestational
5.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K
01:29Chronic Pancreatitis II: Collaborative Care
447
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
447